X-linked hypophosphatemia, fibroblast growth factor 23 signaling, and craniosynostosis

被引：0
|
作者：
Grimbly, Chelsey [1 ,2 ]
Graf, Daniel [2 ,3 ]
Ward, Leanne M. [4 ]
Alexander, R. Todd [1 ,2 ]
机构：
[1] Univ Alberta, Dept Pediat, Edmonton Clin Hlth Acad, Edmonton, AB T6G 2R7, Canada
[2] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB T6G 2R7, Canada
[3] Univ Alberta, Dept Dent & Dent Hyg, Edmonton, AB T6G 2R7, Canada
[4] Univ Ottawa, Childrens Hosp Eastern Ontario, Fac Med, Div Endocrinol & Metab,Dept Pediat, Ottawa, ON K1H 8L1, Canada
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2023年 / 248卷 / 22期
关键词：
Rickets; phosphate; craniosynostosis; fibroblast growth factor 23; hypophosphatemia; X-linked hypophosphatemia; ALKALINE-PHOSPHATASE; SAGITTAL SYNOSTOSIS; FGF RECEPTOR; RICKETS; BONE; RESISTANT; PHEX; MINERALIZATION; OSTEOPONTIN; GENE;
D O I：
10.1177/15353702231222023
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
This review summarizes the current knowledge of fibroblast growth factor 23 signaling in bone and its role in the disease pathology of X-linked hypophosphatemia. Craniosynostosis is an under-recognized complication of X-linked hypophosphatemia. The clinical implications and potential cellular mechanisms invoked by increased fibroblast growth factor 23 signaling causing craniosynostosis are reviewed. Knowledge gaps are identified and provide direction for future clinical and basic science studies.
引用
收藏
页码：2175 / 2182
页数：8
相关论文
共 50 条
  • [31] Growth attenuation of the facial skeleton in X-linked dominant hypophosphatemia
    Ferguson, DJ
    Witek, CA
    Roy, WA
    JOURNAL OF DENTAL RESEARCH, 1996, 75 : 1887 - 1887
  • [32] X-LINKED HYPOPHOSPHATEMIA: UNDERSTANDING AND MANAGEMENT
    Imel, E. A.
    Peacock, M.
    DRUGS OF THE FUTURE, 2010, 35 (09) : 755 - 763
  • [33] DISEASE BURDEN OF X-LINKED HYPOPHOSPHATEMIA
    Luis Yanes, M., I
    Diaz Curiel, M.
    Vicente Calderon, C.
    Peris Bernal, P.
    Marin del Barrio, S.
    Ramon Krauel, M.
    Hernandez Jaras, J.
    Broseta Monzo, J. J.
    Espinosa Roman, L.
    Mendizabal, S.
    Perez Sukia, L.
    Martinez Jimenez, V
    Palazon, C.
    Juan, P.
    Calleja, M. A.
    Ariceta, G.
    Montesdeoca, P.
    Jimenez, A.
    Nieto, I
    VALUE IN HEALTH, 2019, 22 : S865 - S865
  • [34] Calcitonin Administration in X-Linked Hypophosphatemia
    Liu, Eva S.
    Carpenter, Thomas O.
    Gundberg, Caren M.
    Simpson, Christine A.
    Insogna, Karl L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (17): : 1678 - 1680
  • [35] Management of X-linked hypophosphatemia in adults
    Lecoq, Anne-Lise
    Brandi, Maria Luisa
    Linglart, Agnes
    Kamenicky, Peter
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 103
  • [36] Burosumab for Pediatric X-Linked Hypophosphatemia
    Imel, Erik A.
    CURRENT OSTEOPOROSIS REPORTS, 2021, 19 (03) : 271 - 277
  • [37] Anthropometric characteristics of X-linked hypophosphatemia
    Pronicka, E
    Popowska, E
    Rowinska, E
    Arasimowicz, E
    Syczewska, M
    Jurkiewicz, D
    Lebiedowski, M
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 126A (02): : 141 - 149
  • [38] Joint replacement in X-linked hypophosphatemia
    Mills, Emily S.
    Iorio, Louis
    Feinn, Richard S.
    Duignan, Kevin M.
    Macica, Carolyn M.
    JOURNAL OF ORTHOPAEDICS, 2019, 16 (01) : 55 - 60
  • [39] New insights into X-linked hypophosphatemia
    Grieff, M
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1997, 6 (01): : 15 - 19
  • [40] CARDIOVASCULAR MANIFESTATIONS IN X-LINKED HYPOPHOSPHATEMIA
    Hernandez-frias, Olaya
    Gil-pena, Helena
    Ma Perez-roldan, Jose
    Gonzalez-sanchez, Susana
    Fuente-perez, Rocio
    Fernandez-iglesias, Angela
    Rodriguez-rubio, Enrique
    Santos, Fernando
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1973 - 1974
12345